Colby R Ayers
Overview
Explore the profile of Colby R Ayers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
4595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hall E, Ayers C, Hendren N, Clark C, Saha A, Beaini H, et al.
Am J Cardiol
. 2025 Jan;
PMID: 39864767
Data regarding cardiogenic shock (CS) from safety-net hospitals serving socioeconomically-disadvantaged patients are limited. In addition, little is known regarding long-term outcomes and management of heart failure-related CS (HF-CS), a population...
2.
Patel K, Saha A, Ayers C, Rohatgi A, Berry J, Almandoz J, et al.
JACC Adv
. 2024 Jun;
2(1):100174.
PMID: 38939024
Background: High-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are cardiac biomarkers commonly detected in adults with type 2 diabetes (T2D) and are associated with heart failure...
3.
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis
Pandey A, Patel K, Segar M, Shapiro M, Ballantyne C, Virani S, et al.
JACC Heart Fail
. 2024 May;
12(7):1242-1253.
PMID: 38752934
Background: High-density lipoprotein (HDL) is commonly characterized by its cholesterol concentration (HDL-C) and inverse association with atherosclerotic cardiovascular disease. Objectives: The authors sought to evaluate the association of HDL particle...
4.
Hall E, Ayers C, Kolkailah A, Rutan C, Walchok J, Williams 4th J, et al.
Circ Cardiovasc Qual Outcomes
. 2023 Apr;
16(5):e009652.
PMID: 37017087
Background: The COVID-19 pandemic has evolved through multiple phases characterized by new viral variants, vaccine development, and changes in therapies. It is unknown whether rates of cardiovascular disease (CVD) risk...
5.
Zuo Y, Navaz S, Liang W, Li C, Ayers C, Rysenga C, et al.
JAMA Netw Open
. 2023 Apr;
6(4):e236530.
PMID: 37014642
Importance: The prevalence of antiphospholipid antibodies (aPL) and their association with future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly investigated. Objective: To determine the association between measurements...
6.
Thibodeau J, Ravipati G, Pham D, Ayers C, Hardin E, Chin K, et al.
Circ Heart Fail
. 2023 Feb;
16(2):e010169.
PMID: 36809040
No abstract available.
7.
Badia R, Pradhan R, Ayers C, Chandra A, Rohatgi A
J Clin Lipidol
. 2022 Dec;
17(1):124-130.
PMID: 36464598
Background: Small studies have suggested that moderate alcohol consumption increases HDL cholesterol (HDL-C) levels and cholesterol efflux capacity (CEC), a main anti-atherosclerotic HDL function. Objectives: This study aimed to understand...
8.
Riggs K, Joshi P, Khera A, Otvos J, Greenland P, Ayers C, et al.
Am J Prev Cardiol
. 2022 Sep;
12:100373.
PMID: 36061365
Objective: Inflammatory markers are associated with cardiovascular disease (CVD); however, the ability to specifically predict myocardial infarction (MI) as well as ischemic stroke remains unknown. There has not been a...
9.
Rosenblatt A, Ayers C, Rao A, Howell S, Hendren N, Zadikany R, et al.
Circ Arrhythm Electrophysiol
. 2022 Apr;
15(5):e010666.
PMID: 35475654
Background: New-onset atrial fibrillation (AF) in patients hospitalized with COVID-19 has been reported and associated with poor clinical outcomes. We aimed to understand the incidence of and outcomes associated with...
10.
Mauricio R, Singh K, Sanghavi M, Ayers C, Rohatgi A, Vongpatanasin W, et al.
Atherosclerosis
. 2022 Mar;
346:46-52.
PMID: 35276530
Background And Aims: Soluble Fms-like tyrosine kinase-1 (sFlt-1) plays a role in angiogenesis, atherogenesis, and preeclampsia. The relationship of sFlt-1 with markers of subclinical atherosclerosis and future atherosclerotic cardiovascular disease...